December 12, 2013

Merial Receives EMA approval for Broadline™ for Broad Spectrum Parasite Treatment and Prevention in Cats

New Product is a Broad Spectrum Topical Feline Endectocide from Sanofi’s Animal Health Division, Adds to Company’s Strong Parasiticide Portfolio

 

Merial Receives EMA approval for Broadline™ for Broad Spectrum Parasite Treatment and Prevention in Cats
New Product is a Broad Spectrum Topical Feline Endectocide from Sanofi’s Animal Health Division, Adds to Company’s Strong Parasiticide Portfolio

Paris, France – December 12, 2013 – Sanofi (EURONEXT: SAN and NYSE: SNY) and its animal health division Merial today announced the approval by the European Medicines Agency (EMA) of BroadlineTM, a unique product in the fight against external parasites offering additional internal parasite control for cats and kittens.